XT
PMVP icon

XTX Topco’s PMV Pharmaceuticals PMVP Stock Holding History

XTX Topco’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-104,485
Closed -$131K – 4251
2025
Q4 		$131K Buy
104,485
+61,723
+144% +$82.7K ﹤0.01% 2558
2025
Q3 		$59.9K Buy
+42,762
New +$59.2K ﹤0.01% 2133
2025
Q1 		– Sell
-10,877
Closed -$16.4K – 2945
2024
Q4 		$16.4K Sell
10,877
-13,283
-55% -$21K ﹤0.01% 2075
2024
Q3 		$36K Sell
24,160
-123,382
-84% -$191K ﹤0.01% 1751
2024
Q2 		$239K Sell
147,542
-47,464
-24% -$85.6K 0.02% 1107
2024
Q1 		$332K Sell
195,006
-54,406
-22% -$102K 0.04% 766
2023
Q4 		$773K Buy
+249,412
New +$660K 0.17% 75
2023
Q3 		– Sell
-27,225
Closed -$170K – 1916
2023
Q2 		$170K Buy
+27,225
New +$143K 0.03% 1060
2022
Q4 		– Sell
-19,134
Closed -$228K – 1429
2022
Q3 		$228K Buy
+19,134
New +$276K 0.06% 700

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

XTX Topco's PMVP Position: Q1 2026 in Review

XTX Topco sold out of PMV Pharmaceuticals (PMVP) in Q1 2026, closing a stake of 104,485 shares — an estimated $131K sold.

XTX Topco first reported a position in PMVP in Q3 2022 and held it in 9 quarters. The position peaked at $773K in Q4 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • XTX Topco reported no remaining PMV Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 104,485 PMV Pharmaceuticals shares in Q1 2026, an estimated $131K.
  • XTX Topco first reported a position in PMV Pharmaceuticals in Q3 2022 and held it in 9 quarters.
  • XTX Topco's PMV Pharmaceuticals position peaked at $773K in Q4 2023.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.